Tamoxifen and pregnancy: an absolute contraindication?
TN Schuurman, PO Witteveen, E Van der Wall… - Breast Cancer Research …, 2019 - Springer
Purpose Breast cancer is the most common malignancy among young women of reproductive
age. Adjuvant treatment with tamoxifen reduces the risk of recurrence in hormone-…
age. Adjuvant treatment with tamoxifen reduces the risk of recurrence in hormone-…
Predictive value of each geriatric assessment domain for older patients with cancer: a systematic review
CP Bruijnen, DG van Harten-Krouwel… - Journal of geriatric …, 2019 - Elsevier
Background A geriatric assessment (GA) is increasingly used to help guide treatment decisions
in older patients with cancer. However, there is no consensus regarding which domains …
in older patients with cancer. However, there is no consensus regarding which domains …
Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
M Walraven, PO Witteveen, MPJ Lolkema… - Angiogenesis, 2011 - Springer
Anti-VEGF (vascular endothelial growth factor) therapy with the monoclonal antibody
bevacizumab can cause gastrointestinal (GI) perforations. In recent years it became apparent that …
bevacizumab can cause gastrointestinal (GI) perforations. In recent years it became apparent that …
[HTML][HTML] ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours …
The development of guidelines recommendations is one of the core activities of the European
Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (…
Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (…
Pan-cancer whole-genome analyses of metastatic solid tumours
Metastatic cancer is a major cause of death and is associated with poor treatment efficacy. A
better understanding of the characteristics of late-stage cancer is required to help adapt …
better understanding of the characteristics of late-stage cancer is required to help adapt …
An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity
O Kopper, CJ De Witte, K Lõhmussaar… - Nature medicine, 2019 - nature.com
Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage. Experimental
in vitro models that faithfully capture the hallmarks and tumor heterogeneity of OC are …
in vitro models that faithfully capture the hallmarks and tumor heterogeneity of OC are …
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study
F Amant, G von Minckwitz, SN Han… - Journal of clinical …, 2013 - ascopubs.org
Purpose We aimed to determine the prognosis of patients with breast cancer diagnosed
during pregnancy (BCP). Patients and Methods In this cohort study, a multicentric registry of …
during pregnancy (BCP). Patients and Methods In this cohort study, a multicentric registry of …
A phase I study of the cyclin-dependent kinase 4/6 inhibitor ribociclib (LEE011) in patients with advanced solid tumors and lymphomas
JR Infante, PA Cassier, JF Gerecitano… - Clinical Cancer …, 2016 - AACR
Purpose: Ribociclib (an oral, highly specific cyclin-dependent kinase 4/6 inhibitor) inhibits
tumor growth in preclinical models with intact retinoblastoma protein (Rb + ). This first-in-…
tumor growth in preclinical models with intact retinoblastoma protein (Rb + ). This first-in-…
Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter-and intrapatient drug responses
CJ de Witte, JE Valle-Inclan, N Hami, K Lõhmussaar… - Cell reports, 2020 - cell.com
There remains an unmet need for preclinical models to enable personalized therapy for
ovarian cancer (OC) patients. Here we evaluate the capacity of patient-derived organoids (PDOs…
ovarian cancer (OC) patients. Here we evaluate the capacity of patient-derived organoids (PDOs…
Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer …
CN Nomden, AAC De Leeuw, JM Roesink… - Radiotherapy and …, 2013 - Elsevier
PURPOSE: To evaluate dosimetric parameters and clinical outcome for cervical cancer
patients treated with chemo-radiation and MR-image guided adaptive brachytherapy (MR-IGABT…
patients treated with chemo-radiation and MR-image guided adaptive brachytherapy (MR-IGABT…